$KNTK

ISQ Global Fund II GP LLC (Wahba Sadek, Bhandari Gautam) sold $2.2M of KNTK (indirect holdings)

ISQ Global Fund II GP LLC sold 38,887 indirectly-held shares of Kinetik Holdings Inc. (KNTK) at an average of $55.94 ($55.07–$56.69, $2.18M total) across 3 trades over 2026-10-30 to 2026-11-03. Filed jointly with I Squared Capital, LLC (10% owner), ISQ Holdings, LLC (10% owner), Wahba Sadek (10% owner) and Bhandari Gautam (10% owner).

Original reporting
SEC EDGAR · ISQ Global Fund II GP LLC, I Squared Capital, LLC, ISQ Holdings, LLC, Wahba Sadek, Bhandari Gautam
Published Nov 3, 2026, 10:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 10:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KNTK
Bearish
medium confidence
Mentioned
$KNTK
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KNTKBearishLow
01

Why it matters

The disclosed sale reduces a major insider's holding but does not alter control. Market reaction is expected to be modest.

02

Market read

A small insider sell in a low‑float stock; likely limited short‑term price effect.

03

What to watch

The transaction was executed via a 10b5‑1 plan, indicating pre‑planned execution, which may mitigate negative interpretation.

Relevance 6/10Novelty 4/10Timing: after-hours today

Background

Kinetik Holdings (KNTK) is a micro‑cap listed on US exchanges, focused on blockchain infrastructure. Insider transactions are closely watched for price cues.

Company-level read

Ticker impact

$KNTKBearishMedium confidence
Context

Form 4 disclosed ISQ Global Fund II GP LLC sold ~38,887 shares of Kinetik Holdings for $2.2M, reducing its stake to 961,114 shares.

Expected impact

likely slight downward pressure as the market prices the insider sell.

Evidence & confidence

A 10% owner sold $2.2M of stock; such insider sales often lead to short-term price softness, especially for a micro‑cap.

Market effects

Minimal impact on the broader biotech/health‑tech sector.

No significant regional effect.

Limited to investors tracking insider activity in micro‑caps.

Counterpoint

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • Kinetik Holdings Inc.

    Issuer of the shares sold.

  • ISQ Global Fund II GP LLC

    Reporting entity and 10% owner.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KNTKMedAI 8/10

Why is Kinetik Holdings stock surging today?

Kinetik Holdings' stock rose 5.2% in after-hours trading after Bloomberg reported the company is exploring strategic alternatives, including a potential sale. The company posted record Q2 2026 results with revenue up 36% YoY and net income more than doubled. Kinetik's management had raised its full-year 2026 guidance. U.S. equities broadly sold off during regular trading hours, with the S&P 500, Dow Jones, and Nasdaq all declining.

Med

Kinetik stock jumps 5% on potential sale exploration report

Kinetik Holdings Inc. (KNT) shares rose 5% in after-hours trading after reports it is exploring strategic options, including a potential sale. The company, backed by Blackstone Inc. (BX), has a market value of $8.9B. No final decision has been made. Kinetik closed regular trading at $54.55, down 0.8% but up 30% over the past year.